NCT00060359View on ClinicalTrials.gov

Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

January 31, 2009

Conditions
Fallopian Tube CarcinomaMalignant Ovarian Mixed Epithelial TumorOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous CystadenocarcinomaOvarian Serous CystadenocarcinomaPrimary Peritoneal CarcinomaStage III Ovarian CancerStage IV Ovarian CancerUndifferentiated Ovarian Carcinoma
Interventions
DRUG

Carboplatin

Given IV

DRUG

Paclitaxel Poliglumex

Given IV

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00060359 - Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter